Reported Jan 15, 2020 · Terminated
Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.
AAA Pharmaceutical, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: AAA Pharmaceutical, Inc. · 681 Main St · Lumberton, NJ · 08048-5013
Is this the product you have?
Ranitidine 150 mg tablets24 count bottlesNDC 37808-196-01
- Lot codes and dates
P134458Sept 2020 P134943Aug 2020 P135840Aug2020 P136622April 2021 P136871April 2021 P137347April 2021 P137424April 2021
- Amount recalled
- 34,272 (24-count bottles)
This recall covers 2 products
The agency filed one notice per product. You are reading one of them; the other one is below.
Why it was recalled
CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new AAA Pharmaceutical, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.